2.74
price up icon0.00%   0.00
after-market Handel nachbörslich: 2.69 -0.05 -1.82%
loading
Schlusskurs vom Vortag:
$2.74
Offen:
$2.76
24-Stunden-Volumen:
17,377
Relative Volume:
0.09
Marktkapitalisierung:
$7.42M
Einnahmen:
$202.00K
Nettoeinkommen (Verlust:
$-28.96M
KGV:
-4.5667
EPS:
-0.6
Netto-Cashflow:
$-21.85M
1W Leistung:
+3.59%
1M Leistung:
+11.84%
6M Leistung:
+2,140%
1J Leistung:
+914.81%
1-Tages-Spanne:
Value
$2.69
$2.7992
1-Wochen-Bereich:
Value
$2.4301
$2.94
52-Wochen-Spanne:
Value
$0.0633
$20.35

AIM ImmunoTech Inc Stock (AIM) Company Profile

Name
Firmenname
AIM ImmunoTech Inc
Name
Telefon
352 448 7797
Name
Adresse
2117 SW Highway 484, Ocala, FL
Name
Mitarbeiter
24
Name
Twitter
@AIMImmuno
Name
Nächster Verdiensttermin
2024-12-15
Name
Neueste SEC-Einreichungen
Name
AIM's Discussions on Twitter

Vergleichen Sie AIM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AIM
AIM ImmunoTech Inc
2.74 7.42M 202.00K -28.96M -21.85M -0.60
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.64 101.35B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.00 58.66B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.27 59.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
737.56 44.01B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
340.70 36.56B 3.81B -644.79M -669.77M -6.24

AIM ImmunoTech Inc Aktie (AIM) Neueste Nachrichten

pulisher
Sep 30, 2025

Why AIM ImmunoTech Inc. stock remains top rated2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Will AIM ImmunoTech Inc. (HXB) stock benefit from Fed rate cutsJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Will AIM ImmunoTech Inc. stock keep raising dividendsJuly 2025 News Drivers & Safe Entry Trade Signal Reports - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Can AIM ImmunoTech Inc. (HXB) stock sustain breakout momentumWeekly Risk Report & Free Verified High Yield Trade Plans - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

How AIM ImmunoTech Inc. (HXB) stock compares with top peersTrade Entry Summary & Long-Term Safe Investment Ideas - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Can AIM ImmunoTech Inc. (HXB) stock hit consensus price targetsProfit Target & Advanced Swing Trade Entry Alerts - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

How AIM ImmunoTech Inc. stock stacks up against competitorsTrade Performance Summary & Verified Swing Trading Watchlists - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

How AIM ImmunoTech Inc. (HXB) stock performs in volatility spikesMarket Risk Analysis & Reliable Price Action Trade Plans - newser.com

Sep 29, 2025
pulisher
Sep 25, 2025

AIM ImmunoTech Secures Patent in Japan Through 2039 for - GlobeNewswire

Sep 25, 2025
pulisher
Sep 25, 2025

AIM ImmunoTech Secures Japan Patent for Ampligen in Cancer Treat - GuruFocus

Sep 25, 2025
pulisher
Sep 25, 2025

AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors - The Manila Times

Sep 25, 2025
pulisher
Sep 25, 2025

Novel Cancer Therapy Patent Victory: AIM ImmunoTech's Ampligen Combo Shows Promise in Phase 2 Trials - Stock Titan

Sep 25, 2025
pulisher
Sep 24, 2025

Analyzing AIM ImmunoTech (NYSE:AIM) and ZIVO Bioscience (NASDAQ:ZIVO) - Defense World

Sep 24, 2025
pulisher
Sep 23, 2025

AIM ImmunoTech Announces Publication of Journal Article On - GlobeNewswire

Sep 23, 2025
pulisher
Sep 22, 2025

AIM ImmunoTech's Ampligen Shows Promise in Cancer Treatment - GuruFocus

Sep 22, 2025
pulisher
Sep 22, 2025

Breakthrough Cancer Treatment: AIM ImmunoTech's Ampligen + Interferon Shows Promise Against 'Cold' Tumors - Stock Titan

Sep 22, 2025
pulisher
Sep 21, 2025

Maxim Group Sees 133% Upside in AIM ImmunoTech Inc. (AIM) - Insider Monkey

Sep 21, 2025

Finanzdaten der AIM ImmunoTech Inc-Aktie (AIM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
Kapitalisierung:     |  Volumen (24h):